Adoptive Cell Transfer of Allogeneic Epstein–Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report

• Bjoern-Thore Hansen,
• Petra Bacher,
• Petra Bacher,
• Britta Eiz-Vesper,
• Steffen M. Heckl,
• Wolfram Klapper,
• Karoline Koch,
• Britta Maecker-Kolhoff,
• Claudia D. Baldus,
• Lars Fransecky

Affiliations

Bjoern-Thore Hansen

Medical Department II – Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany

Petra Bacher

Institute of Immunology, Christian-Albrechts-University of Kiel, Kiel, Germany

Petra Bacher

Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany

Britta Eiz-Vesper

Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany

Steffen M. Heckl

Medical Department II – Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany

Wolfram Klapper

Section for Hematopathology and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany

Karoline Koch

Section for Hematopathology and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany

Britta Maecker-Kolhoff

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

Claudia D. Baldus

Medical Department II – Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany

Lars Fransecky

Medical Department II – Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany